Sunrest Lifescience Limited (NSE:SUNREST)

Market Cap	152.77M -44.4%
Revenue (ttm)	708.33M +112.0%
Net Income	41.16M +105.3%
EPS	9.59 +105.4%
Shares Out	4.29M
PE Ratio	3.71
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,200
Open	35.60
Previous Close	35.60
Day's Range	35.60 - 35.60
52-Week Range	29.55 - 60.70
Beta	0.21
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 13, 2026

About Sunrest Lifescience

Sunrest Lifescience Limited manufactures, sells, and markets healthcare products, medicines, and cosmetic products in India. It markets various drugs, including anti-bacterials, antibiotics, anti-amoeibics, anti- fungals, analgesic, neuropathy, anti-hypertension, anti-inflammatory, anti-ulcerants, anti-cold, anti-cough, anti-allergics, nutritionals, ayurvedic, and cosmetics in various forms, such as tablets, capsules, soft gels, syrup, dry-syrups, injections, cream-ointments, and powders. The company sells its products through a network of dist...

• Industry: Medical - Pharmaceuticals
• Sector: Healthcare
• Founded: 2017
• Employees: 210
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: SUNREST

Financial Performance

In fiscal year 2026, Sunrest Lifescience's revenue was 708.33 million, an increase of 111.99% compared to the previous year's 334.13 million. Earnings were 41.16 million, an increase of 105.27%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 13, 2026

Data Sources Report a data error